Subtopic Deep Dive

TGF-β Tumor Suppression Mechanisms
Research Guide

What is TGF-β Tumor Suppression Mechanisms?

TGF-β tumor suppression mechanisms refer to the cytokine's cytostatic effects inducing cell cycle arrest and apoptosis in premalignant epithelial cells via Smad signaling, which switch to tumor promotion in advanced cancers.

TGF-β inhibits epithelial proliferation through Notch cooperation and Smad-dependent pathways (Niimi et al., 2007, 135 citations). Studies show regulators like Arkadia and RB1CC1 enhance suppression by targeting Smad inhibitors (Sharma et al., 2011, 40 citations; Koinuma et al., 2011, 35 citations). Over 10 key papers document context-dependent loss in hepatocellular and colorectal carcinomas.

Curated Papers

Key Challenges

Why It Matters

Loss of TGF-β cytostasis drives oncogenesis in hepatocellular carcinoma, where reduced TIF1γ expression correlates with metastasis and poor prognosis (Ding et al., 2014, 130 citations). In colorectal cancer, Arkadia-mediated enhancement of TGF-β signaling prevents tumor progression (Sharma et al., 2011). Restoring these mechanisms via EP2 antagonists counters COX-2 inhibition in mammary tumors (Tian and Schiemann, 2009), informing therapies to reverse switches to promotion.

Key Research Challenges

Context-Dependent Signaling Switch

TGF-β shifts from suppressing premalignant growth to promoting metastasis in advanced stages, complicating therapeutic targeting (Yang et al., 2019, 1074 citations). Mechanisms underlying this switch remain unclear across cancer types. Studies highlight variable Smad responses in HCC lines (Dzieran et al., 2013, 79 citations).

Regulator Identification in Tumors

Identifying modulators like CXXC5 and TIF1γ that enforce arrest is challenging due to context-specific expression (Yan et al., 2017, 44 citations; Ding et al., 2014). Loss-of-function mutations evade suppression. Arkadia's role needs validation in diverse models (Sharma et al., 2011).

Cytostasis Resistance Mechanisms

Tumors resist TGF-β arrest via PGE2/EP2 antagonism and p53 rewiring (Tian and Schiemann, 2009; Garcia-Rendueles et al., 2016). Quantifying pathway antagonism requires integrated signaling analysis. Notch dependency adds complexity (Niimi et al., 2007).

Essential Papers

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis

Hao Yang, D.A. Baker, Peter ten Dijke · 2019 · International Journal of Molecular Sciences · 1.1K citations

Transforming growth factor β (TGF-β) is a secreted cytokine that regulates cell proliferation, migration, and the differentiation of a plethora of different cell types. Consistent with these findin...

Notch signaling is necessary for epithelial growth arrest by TGF-β

Hideki Niimi, Katerina Pardali, Michael Vanlandewijck et al. · 2007 · The Journal of Cell Biology · 135 citations

Transforming growth factor β (TGF-β) and Notch act as tumor suppressors by inhibiting epithelial cell proliferation. TGF-β additionally promotes tumor invasiveness and metastasis, whereas Notch sup...

Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma

Zeyang Ding, Guan-nan Jin, Wei Wang et al. · 2014 · Hepatology · 130 citations

Transcriptional intermediary factor 1 gamma (TIF1γ) may play either a potential tumor-suppressor or -promoter role in cancer. Here we report on a critical role of TIF1γ in the progression of hepato...

TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription

Yuki Kawarada, Yasumichi Inoue, Fumihiro Kawasaki et al. · 2016 · Scientific Reports · 80 citations

Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines

Johanna Dzieran, J Fabian, Teng Feng et al. · 2013 · PLoS ONE · 79 citations

Hepatocellular carcinoma (HCC) is a major public health problem due to increased incidence, late diagnosis and limited treatment options. TGF-β is known to provide cytostatic signals during early s...

PGE2 receptor EP2 mediates the antagonistic effect of COX‐2 on TGF‐β signaling during mammary tumorigenesis

Maozhen Tian, William P. Schiemann · 2009 · The FASEB Journal · 58 citations

ABSTRACT The molecular mechanisms that enable cyclooxygenase‐2 (COX‐2) and its mediator prostaglandin E2 (PGE2) to inhibit transforming growth factor‐β (TGF‐β) signaling during mammary tumorigenesi...

CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis

Xiaohua Yan, Jingyi Wu, Quanlong Jiang et al. · 2017 · Journal of Molecular Cell Biology · 44 citations

Evading TGF-β-mediated growth inhibition is often associated with tumorigenesis in liver, including hepatocellular carcinoma (HCC). To better understand the functions and the underlying molecular m...

Reading Guide

Foundational Papers

Start with Niimi et al. (2007, 135 citations) for Notch-TGF-β arrest mechanism; Ding et al. (2014, 130 citations) for TIF1γ in HCC; Dzieran et al. (2013, 79 citations) for Smad cytostasis variation.

Recent Advances

Study Yan et al. (2017, 44 citations) on CXXC5 apoptosis induction; Garcia-Rendueles et al. (2016) on p27 rewiring; Koinuma et al. (2011, 35 citations) on RB1CC1 modulation.

Core Methods

Smad complex assays (Kawarada et al., 2016), EP2 knockdown for antagonism (Tian and Schiemann, 2009), Arkadia ubiquitination (Sharma et al., 2011), HCC line comparisons (Dzieran et al., 2013).

How PapersFlow Helps You Research TGF-β Tumor Suppression Mechanisms

Discover & Search

Research Agent uses citationGraph on Niimi et al. (2007, 135 citations) to map Notch-TGF-β interactions, then findSimilarPapers reveals Arkadia regulators (Sharma et al., 2011). exaSearch queries 'TGF-β cytostasis HCC' surfaces 250M+ OpenAlex papers like Ding et al. (2014). searchPapers filters by citations >50 for high-impact suppression studies.

Analyze & Verify

Analysis Agent applies readPaperContent to extract Smad cytostasis data from Dzieran et al. (2013), then runPythonAnalysis with pandas plots HCC cell line responses vs. controls. verifyResponse (CoVe) cross-checks claims with GRADE grading, verifying EP2 antagonism stats (Tian and Schiemann, 2009). Statistical verification confirms p-values in apoptosis assays.

Synthesize & Write

Synthesis Agent detects gaps in switch mechanisms post-cytostasis, flagging contradictions between early suppression (Niimi et al., 2007) and EMT promotion (Yang et al., 2019). Writing Agent uses latexEditText for pathway diagrams, latexSyncCitations integrates 10 papers, and latexCompile generates review manuscripts. exportMermaid visualizes Smad-Notch networks.

Use Cases

"Analyze cytostasis variation across HCC lines from Dzieran 2013 with stats"

Research Agent → searchPapers(Dzieran) → Analysis Agent → readPaperContent → runPythonAnalysis(pandas dose-response curves, matplotlib apoptosis plots) → statistical output with p-values and GRADE scores.

"Draft LaTeX review on Arkadia enhancing TGF-β suppression in CRC"

Synthesis Agent → gap detection(Sharma 2011) → Writing Agent → latexEditText(manuscript) → latexSyncCitations(10 papers) → latexCompile(PDF) → researcher gets polished, cited review with diagrams.

"Find code for TGF-β Smad signaling simulations in suppression papers"

Research Agent → searchPapers('TGF-β Smad model') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Code Discovery → researcher gets runnable Python models for cytostasis simulations.

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'TGF-β suppression loss', structures reports on switch mechanisms with citationGraph from Niimi et al. (2007). DeepScan's 7-step chain verifies Notch dependency (readPaperContent → CoVe → GRADE). Theorizer generates hypotheses on CXXC5 restoration from Yan et al. (2017) literature synthesis.

Try Doxa for TGF-β Tumor Suppression Mechanisms Research

Frequently Asked Questions

What defines TGF-β tumor suppression?

TGF-β enforces cytostatic growth arrest and apoptosis in premalignant cells via Smad and Notch pathways (Niimi et al., 2007).

What are key methods in this subtopic?

Cell line cytostasis assays, Smad reporter luciferase, ubiquitin ligase knockdowns, and HCC xenografts measure suppression (Dzieran et al., 2013; Sharma et al., 2011).

What are landmark papers?

Niimi et al. (2007, 135 citations) links Notch to arrest; Ding et al. (2014, 130 citations) shows TIF1γ loss in HCC; Sharma et al. (2011, 40 citations) details Arkadia enhancement.

What open problems exist?

Mechanisms of suppression-to-promotion switch, universal regulators across cancers, and therapeutic restoration of cytostasis remain unresolved (Yang et al., 2019; Yan et al., 2017).